The tariffs, set to take effect from October 1, 2025, target only branded and patented medicines unless the manufacturing companies establish production facilities in the United States.
September 26, 2025India’s pharmaceutical industry, often called the “Pharmacy of the World”, supplies over 50 per cent of global vaccine demand, 40 per cent of generics to the US, and 25 per cent of medicines in the UK.
September 26, 2025On India’s approach, Poast described it as pragmatic: “India has taken advantage of discounted Russian oil without endorsing the war. It’s a clear example of realpolitik.”
September 26, 2025Trump defended the tariffs as essential to protect US industry from “large-scale flooding” of imports.
September 26, 2025Washington has levied a 25% tariff on Indian goods, citing New Delhi’s continued imports of Russian crude, in addition to an earlier 25% tariff announced by Trump.
September 13, 2025Siddharth Vora, Head of Quant and Fund Manager, PL Asset Management said, "As market sentiment improves, we are turning bullish on India."
September 12, 2025Goldwyn—who previously served in the US Department of Energy under Presidents Bill Clinton and Barack Obama—said Washington must balance its trade objectives with respect for India’s strategic autonomy.
September 10, 2025Goldwyn, however, criticised Washington’s double standards, calling sanctions on India’s Russian oil imports a “deeply hypocritical policy.”
September 10, 2025In a post on X, PM Modi described India and the US as “natural partners” and voiced confidence in the progress of talks.
September 10, 2025The announcement comes weeks after Washington imposed a 50 per cent tariff on Indian goods, along with an additional 25 per cent penalty on imports of Russian oil.
September 10, 2025Advertisement